Macrophage migration inhibitory factor in pediatric patients undergoing surgery for congenital heart repair.
Macrophage migration inhibitory factor (MIF), a proinflammatory mediator, has been shown to be elevated following heart surgery in adults and may be associated with several postoperative complications, including cardiac and pulmonary dysfunction. In this study, we aimed to measure perioperative plasma MIF, interleukin (IL)-8, and free T4 in 20 children age <4 years undergoing surgical repair of congenital heart lesions with left ventricular volume overload, and to determine whether the response of these mediators determined postoperative outcomes. Plasma samples were obtained preoperatively, immediately on arrival in the pediatric intensive care unit (PICU), and at 12, 24, and 48 h. Patients were continuously monitored in the PICU, and data were recorded daily for therapeutic and monitoring procedures that reflected the invasiveness, intensity, and complexity of care rendered (therapeutic interventional scoring system, TISS). Preoperative plasma MIF, IL-8, and free T4 were not different from age-matched healthy children. However, plasma MIF and IL-8 increased significantly 2 h after completion of cardiopulmonary bypass, and then normalized within 24 h. Peak postoperative levels of MIF (48 +/- 24 ng/mL) and IL-8 (79 +/- 57 pg/mL) correlated significantly with duration of cardiopulmonary bypass. The magnitude of the postoperative increase in plasma MIF was associated with increased number of days required for mechanical ventilation (r = 0.553; P = 0.012), and peak plasma IL-8 correlated significantly with the fraction of inhaled oxygen (FiO(2)) required immediately after surgery (r = 0.510; P = 0.02). Higher circulating MIF levels correlated significantly with increased inotropic support requirements on the second postoperative day, whereas higher postoperative IL-8 levels were associated with higher TISS scores, suggesting increased need for postoperative medical care. These data suggest a potential negative effect of high circulating levels of MIF in the immediate postoperative period on respiratory and cardiovascular functions, and support the development of therapeutic strategies targeting MIF function in this clinical setting.
Merchant
Sanah
S
Department of Pediatrics, Schneider Choldren's Hospital, New Hyde Park, New York, USA.
Nadaraj
Sumekala
S
Chowdhury
Devyani
D
Parnell
Vincent A
VA
Sison
Cristina
C
Miller
Edmund J
EJ
Ojamaa
Kaie
K
D000328:Adult; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D002675:Child, Preschool; D006330:Heart Defects, Congenital / Q000097:blood / Q000601:surgery*; D006801:Humans; D007223:Infant; D016209:Interleukin-8 / Q000097:blood; D007432:Intraoperative Period; D008263:Macrophage Migration-Inhibitory Factors / Q000097:blood*; D011183:Postoperative Complications; D011184:Postoperative Period; D011237:Predictive Value of Tests; D013974:Thyroxine / Q000097:blood; D016896:Treatment Outcome
D016209:Interleukin-8; D008263:Macrophage Migration-Inhibitory Factors; D013974:Thyroxine